As of May 12, 2025, there is no public confirmation of Church & Dwight Co., Inc. planning to acquire a hand sanitizer brand for up to $880 million. The company has been known for strategic acquisitions in the personal care and health sectors, highlighting its focus on broadening its product portfolio.
Historically, Church & Dwight has made significant acquisitions, adding well-known brands to its lineup. In November 2021, the company acquired TheraBreath, a major player in alcohol-free mouthwashes, for $580 million, as reported by Nasdaq. Prior to that, it purchased Zicam for $530 million in December 2020, enhancing its presence in the cold remedy market, according to Finsmes. Furthermore, in September 2022, Church & Dwight bought Hero for $630 million, a leader in acne treatment products, noted Marketscreener.
In the stock market, shares of Church & Dwight Co., Inc. (CHD) were trading at $95.04, showcasing a slight increase of $3.47 or 0.04% from the previous close. The day's trading saw a high of $95.26 and a low of $90.72 with an open price at $91.25. The intraday volume reached 1,384,762 as of the latest trade recorded on Monday, May 12, at 17:15:40 UTC.